V Marco Ranieri Selected Research

Respiratory Acidosis

10/2021	Extracorporeal carbon dioxide removal for treatment of exacerbated chronic obstructive pulmonary disease (ORION): study protocol for a randomised controlled trial.
1/2015	Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control.
1/2010	Extracorporeal CO2 removal.
10/2009	Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Marco Ranieri Research Topics

Disease

29	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 05/2002
18	Sepsis (Septicemia) 01/2022 - 01/2005
12	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 10/2005
11	COVID-19 01/2022 - 01/2020
10	Hypoxia (Hypoxemia) 01/2022 - 02/2005
10	Critical Illness (Critically Ill) 01/2021 - 01/2005
9	Lung Injury 01/2019 - 12/2002
9	Acute Lung Injury 08/2014 - 08/2005
8	Inflammation (Inflammations) 01/2014 - 04/2005
7	Pneumonia (Pneumonitis) 01/2020 - 02/2005
6	Body Weight (Weight, Body) 01/2022 - 03/2005
6	Septic Shock (Toxic Shock Syndrome) 10/2021 - 11/2008
6	Infections 01/2020 - 02/2005
6	Ventilator-Induced Lung Injury 01/2020 - 12/2002
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 02/2012
4	Respiratory Acidosis 10/2021 - 10/2009
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 09/2008
3	Hemorrhage 01/2020 - 02/2011
3	Shock 08/2016 - 03/2006
3	Edema (Dropsy) 01/2016 - 11/2010
3	Reperfusion Injury 01/2016 - 12/2002
3	Lung Diseases (Lung Disease) 08/2014 - 08/2010
3	Human Influenza (Influenza) 02/2013 - 09/2011
2	Acidosis 10/2021 - 01/2020
2	Ventilator-Associated Pneumonia 01/2020 - 04/2010
2	Primary Graft Dysfunction 01/2020 - 01/2016
2	Multiple Organ Failure (MODS) 09/2018 - 12/2002
2	Candidemia 12/2013 - 03/2011
2	Cross Infection (Nosocomial Infection) 02/2012 - 01/2010
2	Proteinuria 09/2008 - 01/2008
2	Neoplasms (Cancer) 03/2006 - 01/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Disease Progression 01/2021
1	Venous Thromboembolism 01/2020
1	Pulmonary Edema 01/2018
1	Hypercapnia 01/2017
1	Ischemia 01/2016
1	Wound Infection (Wound Infections) 08/2014
1	Pathologic Constriction (Stenosis) 08/2014

Drug/Important Bio-Agent (IBA)

9	Carbon DioxideIBA 10/2021 - 10/2009
7	Oxygen (Dioxygen)IBA 01/2022 - 02/2005
4	SteroidsIBA 05/2016 - 04/2005
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2006
3	drotrecogin alfa activated (Xigris)FDA Link 04/2015 - 11/2008
3	Protein CIBA 05/2012 - 11/2008
3	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2010 - 01/2007
3	Soaps (Soap)IBA 03/2006 - 02/2006
2	InterferonsIBA 01/2021 - 01/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2020
2	CytokinesIBA 01/2020 - 01/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 11/2010
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2016
2	LipopolysaccharidesIBA 01/2016 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 02/2010
2	AcidsIBA 01/2013 - 04/2003
2	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2010 - 01/2006
2	EnzymesIBA 09/2010 - 09/2008
2	AlbuminsIBA 01/2008 - 01/2005
2	CreatinineIBA 01/2008 - 07/2006
1	NitrogenIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Prostaglandins DIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Interferon beta-1a FDA Link 11/2017
1	eritoranIBA 08/2016
1	Pancuronium (Pavulon)FDA LinkGeneric 01/2016
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2016
1	Neuromuscular Blocking AgentsIBA 01/2016
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	cisatracurium (Nimbex)FDA Link 01/2016
1	Anidulafungin FDA Link 12/2013
1	EchinocandinsIBA 12/2013
1	Linezolid (Zyvox)FDA Link 10/2013

Therapy/Procedure

26	Artificial Respiration (Mechanical Ventilation) 01/2022 - 12/2002
18	Therapeutics 01/2022 - 02/2005
12	Mechanical Ventilators (Ventilator) 01/2020 - 06/2005
11	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 05/2002
10	Extracorporeal Membrane Oxygenation 01/2020 - 09/2011
6	Noninvasive Ventilation 10/2021 - 10/2005
5	Lung Transplantation 01/2016 - 12/2002
4	Critical Care (Surgical Intensive Care) 10/2020 - 02/2005
4	Continuous Positive Airway Pressure 12/2010 - 02/2005
3	Length of Stay 03/2011 - 02/2005
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2020
2	Transplantation 12/2010 - 10/2010
2	Hemoperfusion 01/2010 - 01/2010
1	Artificial Organs (Artificial Organ) 09/2018
1	Extracorporeal Circulation 01/2017
1	Aftercare (After-Treatment) 01/2016
1	Contraindications 01/2015
1	Tracheostomy 08/2014